ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,338,811 | +2.8% | 43,752 | -14.7% | 0.04% | 0.0% |
| Q1 2023 | $1,302,309 | -36.9% | 51,272 | +0.7% | 0.04% | -39.0% |
| Q4 2022 | $2,064,504 | +48.1% | 50,900 | +20.7% | 0.06% | +28.3% |
| Q3 2022 | $1,394,000 | -20.8% | 42,176 | -15.6% | 0.05% | -9.8% |
| Q2 2022 | $1,760,000 | -26.2% | 49,998 | -3.6% | 0.05% | +6.2% |
| Q1 2022 | $2,384,000 | +69.7% | 51,844 | +144.7% | 0.05% | +77.8% |
| Q4 2021 | $1,405,000 | -15.3% | 21,190 | -20.3% | 0.03% | -35.7% |
| Q3 2021 | $1,659,000 | -5.5% | 26,575 | +25.3% | 0.04% | -25.0% |
| Q2 2021 | $1,756,000 | +14.8% | 21,203 | -8.1% | 0.06% | -1.8% |
| Q1 2021 | $1,530,000 | – | 23,068 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |